Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

InsightsInside the Lab

Guide

Inside the Lab: How We Built an Evidence Gap Map on Respiratory Infection Prevention in Long-Term Care for a Qatar Grant Application

A Qatar-based researcher needed to show grant reviewers what is known, and what is not, about preventing respiratory infections among older adults in long-term care. This is the question they brought us, how we approached it and what we delivered.

Dr. CharlieSenior Medical WriterPublishedReading time7 minutesSources12
  • Evidence gap map
  • Infection prevention
  • Long-term care
  • Qatar

At a glanceInside the Lab

Client
Qatar-based researcher (anonymised)
Purpose
Evidence base for a grant application
Scope
Influenza, RSV, SARS-CoV-2 and pneumonia prevention in long-term care residents
Deliverable
Evidence gap map, gap summary and Qatar evidence review

Talk to our evidence synthesis teamDiscuss your project

Quick answer

  • A Qatar-based researcher asked us for an evidence gap map to justify a grant application on respiratory infection prevention in long-term care.
  • We started from five published reviews, then mapped prevention interventions against outcomes, with pathogen, design and country as filters.
  • The map showed thin evidence for visiting policies, air filtration, staffing and resident well-being, and very little from Qatar.
  • Those gaps became the grant’s rationale and research questions.

The question: evidence for a grant application in Qatar

A researcher based in Qatar was preparing a grant application on preventing respiratory infections among older adults living in long-term care facilities (LTCFs). Grant reviewers expect an application to show what the evidence already says and where it runs out, so the client asked us for an evidence gap map: a structured picture of which prevention measures have been studied, against which outcomes, and where Qatar-specific evidence is missing.

We agreed the scope at the start:

  • Population: older residents of LTCFs (nursing homes, residential and long-stay care).
  • Infections: influenza, respiratory syncytial virus (RSV), SARS-CoV-2 and bacterial pneumonia.
  • Interventions: prevention and control measures, from hand hygiene and testing to visiting policies, ventilation and staffing.
  • Outcomes: infections and outbreaks, hospitalisation and death, staff practice, and residents’ quality of life and function.

The client’s identity and their completed map are confidential. This article describes the brief, our method and the kind of findings the map produced, using only published evidence.

Why the question was harder than it looked

Older residents of long-term care facilities (LTCFs) share rooms, meals and staff, and many live with frailty and chronic illness. Influenza, respiratory syncytial virus (RSV), SARS-CoV-2 and bacterial pneumonia all circulate in these settings. Guidance exists, but it is hard to see which prevention measures have actually been tested, against which outcomes. That is the job of an evidence gap map.

Even the basic burden is uncertain. A systematic review by Childs and colleagues included 26 studies of unvaccinated residents aged 60 or over. Sixteen (62%) reported on pneumonia, seven (27%) on RSV and three (12%) on influenza. Influenza incidence ranged from 5.9% to 85.2%, RSV incidence from 1.1% to 13.5%, and pneumonia prevalence from 1.4% to 55.8%. The authors concluded that estimates this wide give little guidance for decisions, and that large, well-designed epidemiological studies are still needed1.

A 2026 scoping review of seasonal respiratory viruses reached a similar conclusion from a different angle. Of 117 studies, most focused on influenza and on attack rate, lower respiratory tract infection, hospitalisation and death. There was little evidence on other viruses, or on quality of life and functional status2.

How we approached it: start from what reviews already show

We did not start from a blank page. Five reviews define much of the current evidence base on respiratory infection prevention in long-term care facilities, and each one marks out its own gaps.

Table 1. What five reviews already tell a map of respiratory infection prevention in long-term care

ReviewScopeWhat it reportsWhat it leaves open
Childs et al., 20191Burden of influenza, RSV and pneumonia in unvaccinated residents aged 60+26 studies; estimates varied widelyCredible burden figures; the authors call for large epidemiological studies
Lee et al., 20193IPC programmes against healthcare-associated infections in LTCFs, 2007–201617 studies; education, monitoring and feedback reported as successfulNo study implemented all WHO core components
Arnold et al., 20244Non-pharmacological measures against viral respiratory infections16 studies, all in high-income countries; mostly SARS-CoV-2Visiting restrictions, pre-entry testing, air filtration
Cho et al., 20265Non-pharmacological interventions, 2008–202518 studies; multimodal cleaning plus education showed the most positive impactGuidelines, surveillance methods, workload, staffing and bed occupancy
Kolodziej et al., 20262Clinical impact of seasonal respiratory viruses (not SARS-CoV-2)117 studies; most on influenza and conventional outcomesRhinovirus, parainfluenza, hMPV and other viruses; quality of life and functional status

Read together, they show that most intervention evidence concerns non-pharmacological measures, mostly evaluated during COVID-19, in high-income countries4. The reviews also disagree in emphasis. Cho and colleagues found built-environment interventions among the most studied5, while Arnold and colleagues found no evidence on air filtration specifically4. A map has to code these categories precisely so that such differences stay visible.

Planning an evidence gap map or review on infection prevention?

Pubrica’s evidence synthesis team frames the question, builds the mapping framework, runs the systematic search, codes studies and delivers the map with a structured report.

Methodology: interventions mapped against outcomes

For this topic we would set prevention interventions as rows and outcomes as columns. Pathogen (influenza, RSV, SARS-CoV-2, pneumonia, other viruses), study design and country would be filters, not extra axes. That keeps the matrix readable while letting a user check, for example, whether a cell is filled only by COVID-19 studies.

Table 2. Illustrative map: interventions (rows) by outcomes (columns), filled only with what the cited reviews report. No study counts; not results.

InterventionInfections and outbreaksHospitalisation and deathStaff practice and complianceQuality of life and function
Hand hygiene and combined measuresCan be effective, moderate certainty4To be codedTo be codedTo be coded
Education, monitoring and feedbackReported reductions; Lee covers all healthcare-associated infections35To be codedStaff performance outcomes studied3To be coded
Routine testing and surveillanceTesting may be effective, low certainty4To be codedSurveillance methods: limited attention5To be coded
Staff cohorting and compartmentalisationMay be effective, low certainty4To be codedTo be codedTo be coded
Visiting restrictions and pre-entry testingGap flagged4Gap flagged4To be codedTo be coded
Air filtration and ventilationAir filtration: gap flagged4Air filtration: gap flagged4To be codedTo be coded
Staffing, workload and bed occupancyLimited attention5To be codedTo be codedTo be coded
Vaccination (influenza, COVID-19, RSV, pneumococcal)Outside these reviews; separate searchOutside these reviews; separate searchOutside these reviews; separate searchOutside these reviews; separate search

The outcome columns are deliberate. The WHO interim guidance for LTCFs aims both to keep the virus out of facilities and to support safe visiting for residents’ well-being6. A map that only counts infections cannot show whether a measure such as visiting restrictions has been weighed against its effect on residents.

Published evidence only

The client’s completed map is confidential. Table 2 shows the framework populated only with what the five published reviews report. “To be coded” marks cells these reviews do not address, not cells with no evidence.

How the map was built

We used our standard evidence gap map method, adapted to the agreed scope:

  1. Sources to search: MEDLINE, Embase, CINAHL and Cochrane CENTRAL, the databases these reviews used345; COVID-19 study registries, as Arnold and colleagues searched4; and grey literature such as WHO guidance and national public health reports.
  2. What counts as a study: primary studies of residents in LTCFs (nursing homes, residential and long-stay care) that evaluate a prevention or control intervention against a respiratory outcome. Randomised and non-randomised designs are both eligible. Burden studies are kept as a separate context layer, and systematic reviews are coded to show where synthesis already exists. Hospital-only studies are excluded.
  3. How cells are filled: two reviewers code each study to every intervention and outcome it reports, piloting on a sample first. Each cell then shows the number of studies, their designs and, where a review has graded it, the certainty of evidence. This follows Campbell guidance, which treats a map as a systematic product with explicit eligibility criteria, a comprehensive search and systematic coding7.
  4. How gaps are read: an empty cell means “not studied”, not “does not work”. A cell filled only by low-certainty, single-pathogen or single-country studies is a different kind of gap from an empty one, and the map reports the two separately.

What the Qatar focus added

Our PubMed searches found very little Qatar-specific evidence on respiratory infection prevention in long-term care. That scarcity became one of the map’s main findings, and a point the application could make directly.

  • Local settings: published Qatari studies describe long-term care at Rumailah Hospital and Enaya Specialized Care Center8. The one LTCF outbreak report we found describes 24 COVID-19 cases among elderly residents, attenders and front-line staff in June 2020, with lapses such as improper use of personal protective equipment before stricter controls contained it9.
  • Surveillance data: national data already supported a retrospective cohort of residents aged 50 or over, in which primary-series and booster COVID-19 vaccination sharply reduced the risk of severe, critical or fatal disease10. Whether these records can identify LTCF residents, and cover influenza or RSV, would need to be established.
  • Vaccination programmes: an expert panel reports that influenza vaccination coverage in Qatar remains low among older people despite annual campaigns and free vaccines11. A regional analysis of WHO/UNICEF reporting data gave Qatar a median influenza coverage of 65.6% among health care workers for 2018–202412. We found no published coverage figures for LTCF residents or staff.

A Qatar map would therefore draw on regional journals and Ministry of Public Health reports as well as databases. It should also show where it relies on evidence from other countries.

What we delivered for the grant application

The client received three linked outputs, written so they could be lifted into the application:

  1. The evidence gap map: interventions against outcomes, filterable by pathogen, study design and country, with each cell showing the number and type of studies.
  2. A gap summary: each gap stated in one or two sentences with its supporting evidence, separating empty cells from cells filled only by low-certainty or single-country studies.
  3. A Qatar evidence section: what local and Gulf evidence exists, and what the application has to borrow from other countries.

Together these gave the application a documented rationale and a set of research questions grounded in the evidence:

  • Beyond COVID-19, which interventions have been tested against influenza, RSV or other seasonal viruses in LTCFs?
  • How many cells rest only on observational studies from high-income countries?
  • Have visiting policies, air filtration and staffing been evaluated, or only recommended?
  • Does any study measure quality of life, function or isolation effects alongside infection outcomes?
  • What exists from Qatar or other Gulf states, and what must be borrowed from elsewhere?

The answers decide the next step: a focused systematic review where cells are full, or primary research, such as a multicentre burden study, where they are empty.

How Pubrica can help with your grant application

Funders increasingly ask applicants to show that a proposal addresses a real evidence gap. Pubrica’s evidence synthesis team builds evidence gap maps, scoping reviews and systematic reviews scoped to a grant’s aims, and our writers help turn the findings into the background and rationale sections of the application. Every map states its scope, sources and limits, so reviewers can see exactly what it covers.

Pubrica team verdict

An evidence gap map is most useful to a grant application when it separates “not studied” from “studied weakly”, and when local scarcity, as in Qatar, is shown rather than assumed.

Frequently asked questions

It depends on the question. In a 2019 review of burden in unvaccinated residents, 16 of 26 studies covered pneumonia. In a 2026 review of seasonal viruses, most studies covered influenza.

One 2024 review found that combined measures and hand hygiene can be effective, with moderate certainty. Certainty was low or very low for most other measures and outcomes.

Yes. It shows reviewers what has already been studied and where the evidence runs out, which turns the application’s rationale from an assertion into a documented gap.

Very little. We found one COVID-19 outbreak report from a Qatari long-term care facility and no published vaccination coverage for residents.

No. The client is anonymised and their map is confidential. This article uses only published reviews and studies to show the method and the kind of gaps the map found.

Sources

Sources were checked on 19 November 2026. Requirements and guidance may change after that date; confirm the current version with the issuing body.

  1. 1Childs A, Zullo AR, Joyce NR, et al. The burden of respiratory infections among older adults in long-term care: a systematic review. BMC Geriatr. 2019;19(1):210. https://doi.org/10.1186/s12877-019-1236-6
  2. 2Kolodziej LM, Grootegoed LC, van Buul LW, et al. The impact of respiratory viruses on older adults in long-term care facilities: a scoping review. Clin Microbiol Infect. 2026;32(2):239–250. https://doi.org/10.1016/j.cmi.2025.11.002
  3. 3Lee MH, Lee GA, Lee SH, Park YH. Effectiveness and core components of infection prevention and control programmes in long-term care facilities: a systematic review. J Hosp Infect. 2019;102(4):377–393. https://doi.org/10.1016/j.jhin.2019.02.008
  4. 4Arnold L, Bimczok S, Schütt H, Lisak-Wahl S, Buchberger B, Stratil JM. How to protect long-term care facilities from pandemic-like events? - A systematic review on the effectiveness of non-pharmacological measures to prevent viral respiratory infections. BMC Infect Dis. 2024;24(1):589. https://doi.org/10.1186/s12879-024-09271-7
  5. 5Cho E, Lee S, Yang M, Cho J, Hwang S, Kim E. Controlling respiratory infections in long-term care facilities: a systematic review. Int J Nurs Stud. 2026;184:105684. https://doi.org/10.1016/j.ijnurstu.2026.105684
  6. 6World Health Organization. Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update: interim guidance, 8 January 2021. Geneva: World Health Organization; 2021. WHO/2019-nCoV/IPC_long_term_care/2021.1. https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC_long_term_care-2021.1
  7. 7White H, Albers B, Gaarder M, et al. Guidance for producing a Campbell evidence and gap map. Campbell Syst Rev. 2020;16(4):e1125. https://doi.org/10.1002/cl2.1125
  8. 8AlFehaidi AAAHZ, Khan SHU, Abdelrahman RA, et al. Predictors of malnutrition among older residents in Qatari long-term care facilities: a retrospective study. BMC Nutr. 2024;10(1):23. https://doi.org/10.1186/s40795-024-00827-z
  9. 9Al Hamad H, Malkawi MMM, Al Ajmi JAAA, Al-Mutawa MNJH, Doiphode SH, Sathian B. Investigation of a COVID-19 outbreak and its successful containment in a long term care facility in Qatar. Front Public Health. 2021;9:779410. https://doi.org/10.3389/fpubh.2021.779410
  10. 10Mahmoud MA, Ayoub HH, Coyle P, et al. SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: a national cohort study. Influenza Other Respir Viruses. 2023;17(11):e13224. https://doi.org/10.1111/irv.13224
  11. 11Al-Maslamani M, Kassianos G, El Awad K, et al. Expert opinion on improving influenza vaccination coverage rate in Qatar: strategic solutions and role of live attenuated influenza vaccine (LAIV). Hum Vaccin Immunother. 2026;22(1):2628383. https://doi.org/10.1080/21645515.2026.2628383
  12. 12Awaidy STA, Mujaini SA, Koul PA, AlHammadi A, Meslé MM. Examining seasonal influenza vaccination coverage in the Gulf Cooperation Council countries: strengthening prevention and control. IJID Reg. 2026;19:100880. https://doi.org/10.1016/j.ijregi.2026.100880

respiratory infection prevention in long-term care facilitiesrespiratory infections in older adultsinfection prevention and controlinfluenza and RSV preventionlong-term care infection controlrespiratory infection evidence gaps

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation, so check its guide if it has one.

Dr. Charlie. (2026, November 19). Inside the Lab: How We Built an Evidence Gap Map on Respiratory Infection Prevention in Long-Term Care for a Qatar Grant Application. Pubrica. https://pubrica.com/insights/inside-the-lab/evidence-gap-map-respiratory-infection-long-term-care-qatar/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.